Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Work In Process (2020 - 2021)

NovaBridge Biosciences (NBP) reported Work In Process of $39.7 million for Q4 2021, up 15.69% year-over-year from $34.3 million in Q4 2020, and up 15.69% on a QoQ basis from $34.3 million in Q4 2020.

NovaBridge Biosciences (NBP) has 2 years of Work In Process data on file, last reported at $39.7 million in Q4 2021.

  • Quarterly Work In Process rose 15.69% year-over-year to $39.7 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $39.7 million (up 15.69% YoY) and the FY2021 annual result came in at $39.8 million, up 14.28% from the prior year.
  • Work In Process rose to $39.7 million in Q4 2021 per NBP's latest filing, from $34.3 million in the prior quarter.
  • Across five years, Work In Process topped out at $39.7 million in Q4 2021 and bottomed at $34.3 million in Q4 2020.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 39.69 Mn
Dec 31, 2020 34.31 Mn